Saturday, August 1, 2026

The MBCGA Reclaiming Life Program

SURVIVORSHIP: A STRATEGY FOR RECLAIMING LIFE

Developed from interviews with male breast cancer survivors

A diagnosis of male breast cancer changes life immediately. Before treatment even begins, a man may experience disbelief, fear, anger, and profound uncertainty. Because breast cancer is commonly perceived as a women’s disease, many men enter this experience without ever imagining that they could be at risk. Some feel isolated or embarrassed. Others struggle to explain the diagnosis to family members, friends, or colleagues. Almost all confront the frightening questions of whether the cancer has spread, whether treatment will work, and what their future will hold.

Treatment introduces another set of realities. Surgery may involve a mastectomy, lymph-node removal, scarring, chest-wall tightness, weakness, and changes in body image. Chemotherapy can produce fatigue, neuropathy, nausea, cognitive difficulties, and prolonged physical depletion. Radiation may cause skin damage, discomfort, and restricted mobility. Hormonal therapies can affect weight, mood, sexual health, sleep, energy, and concentration. Even after active treatment concludes, the body may continue carrying the consequences.

Survivors frequently discover that completing treatment does not mean that life immediately returns to normal. The medical appointments may become less frequent, but fear of recurrence can remain. Relationships may have changed. Work may feel more demanding. Intimacy and self-confidence may have been disrupted. The individual who entered treatment is not always the same person who emerges from it.

For this reason, survivorship must be understood as more than rehabilitation. Rehabilitation addresses specific physical or functional problems. Survivorship requires a broader strategy for reclaiming one’s life. It is a deliberate program that helps the survivor recover from treatment, restore a meaningful quality of life, and establish a long-term plan for protecting the future.


The MBCGA Reclaiming Life Program

The proposed MBCGA Reclaiming Life Program is a three-stage survivorship model: Recovery, Restorative Living, and Future Maintenance. Each stage recognizes that physical health, mental health, relationships, purpose, and recurrence prevention are interconnected.

Stage One: Recovery

Recovery begins with a comprehensive post-treatment assessment. The survivor and his healthcare team identify the continuing effects of surgery, radiation, chemotherapy, hormonal therapy, and other procedures. This may include pain, lymphedema, neuropathy, weakness, limited range of motion, fatigue, sleep disruption, sexual-health concerns, anxiety, depression, or cognitive changes.

An individualized recovery plan may incorporate physical therapy, strength and mobility training, lymphedema management, nutritional guidance, pain care, mental-health support, and appropriate medical evaluation. Recovery should be gradual and measurable. The objective is not to force the survivor back into his former routine, but to help him understand his changed body and safely rebuild strength, confidence, and independence.

Stage Two: Restorative Living

Once immediate treatment effects are being addressed, survivorship enters a restorative stage. Restoration means creating a life that is not defined exclusively by cancer. This may involve returning to work, rebuilding intimacy, reconnecting with family and friends, resuming travel or recreation, and rediscovering personal interests.

Emotional restoration is equally important. Men may need a safe place to discuss vulnerability, altered body image, fear, masculinity, sexuality, and the pressure to appear strong. Counseling, peer groups, couples therapy, and survivor networks can help normalize these experiences. The goal is not necessarily to return to the person one was before cancer. It is to build a fulfilling life around the person one has become.

Restorative living also encourages purpose. Some survivors find meaning through advocacy, mentoring newly diagnosed men, participating in research, or educating their communities. Others reclaim life privately through family, creativity, faith, work, or service. There is no single definition of a successful survivorship experience.

Stage Three: Future Maintenance

The third stage establishes an ongoing strategy to reduce health risks and identify possible recurrence as early as possible. Survivors need a written follow-up plan developed with their oncology and primary-care teams. It should identify recommended clinical examinations, appropriate imaging or laboratory monitoring, medication management, and symptoms that require medical attention.

Future maintenance also includes regular physical activity, balanced nutrition, weight management, adequate sleep, reduced alcohol use, avoidance of tobacco, and management of cardiovascular, metabolic, and bone health. Genetic counseling may be especially important because male breast cancer can be associated with inherited mutations that may affect both the survivor and his relatives.

No program can guarantee that cancer will not return. However, consistent medical surveillance and healthier living can give survivors a stronger sense of participation in their future.

Survivorship is not a single milestone reached at the end of treatment. It is an evolving commitment to recovery, restoration, and continued vigilance. Reclaiming life does not mean forgetting what happened. It means refusing to allow cancer to determine everything that happens next.



Afterthought: Fight Recurrence—A Lifelong Post-Cancer Plan

Survivorship does not end when treatment ends. It becomes a lifelong commitment to remaining informed, attentive, and actively engaged in one’s health. Fighting recurrence means developing a personalized post-cancer plan with the medical team and following it consistently—not from a place of constant fear, but from a position of preparedness and personal strength.

This plan should include scheduled oncology follow-ups, recommended examinations and imaging, medication adherence, monitoring for new or changing symptoms, and routine assessment of cardiovascular, metabolic, hormonal, bone, and mental health. Genetic counseling may also help identify inherited risks that could affect the survivor and members of his family.

A recurrence-conscious lifestyle includes regular exercise, nutritious eating, healthy weight management, restorative sleep, limited alcohol consumption, avoidance of tobacco, stress management, and meaningful social connection. Mental-health support remains important because fear of recurrence can itself interfere with quality of life.

No lifestyle or surveillance program can guarantee that cancer will never return. However, a coordinated, lifelong plan can help identify concerns earlier, strengthen overall health, and restore a sense of control.

The objective is not to spend every day expecting cancer. It is to move forward with awareness, purpose, and determination. Fight recurrence by protecting the life you worked so hard to reclaim.

REHABILITATION AFTER MALE BREAST CANCER

(For Website: MBCGlobalAlliance.org)

Rebuilding Health, Confidence, and Quality of Life

Completing treatment for male breast cancer is a significant milestone, but it does not always mean that recovery is complete. Surgery, mastectomy, lymph-node procedures, radiation therapy, chemotherapy, hormone therapy, targeted treatments, and other medical interventions can produce lasting physical and emotional effects. Rehabilitation provides a structured path toward restoring health, rebuilding confidence, and returning to a meaningful life.

Rehabilitation is not limited to physical recovery. It is about quality of life.


Restoring Physical Health

Male breast cancer treatments can affect many systems of the body. A mastectomy or lymph-node procedure may cause pain, scar-tissue restriction, numbness, weakness, reduced shoulder mobility, or lymphedema. Radiation may contribute to skin changes, tightness, fatigue, or sensitivity in the treated area. Systemic treatments may affect energy, muscle strength, balance, nerve function, weight, cardiovascular health, and overall endurance.

A comprehensive post-treatment evaluation can identify these concerns and guide an individualized rehabilitation plan. Depending on the survivor’s needs, rehabilitation may include physical therapy, occupational therapy, lymphedema management, supervised exercise, nutritional counseling, pain management, and ongoing medical monitoring.

Exercise should begin gradually and, when appropriate, under professional supervision. Walking, stretching, resistance training, balance exercises, and low-impact cardiovascular activity can help restore strength and mobility. Progress may be gradual, but consistency is more important than intensity. The objective is to rebuild safely and sustainably.

Supporting Mental and Emotional Health

The emotional impact of male breast cancer does not necessarily end when active treatment is completed. Survivors may experience anxiety about recurrence, depression, sleep disruption, changes in body image, or uncertainty about the future.

Men may also feel isolated because breast cancer is commonly portrayed as a women’s disease. Some may feel uncomfortable discussing their diagnosis, surgical changes, or emotional needs. This lack of visibility can make the survivorship experience more difficult.

Mental-health support should be an essential part of rehabilitation. Counseling, survivor networks, peer-support groups, stress-management practices, and honest conversations with family members can help men process what they have experienced. Seeking emotional support is not a sign of weakness. It is a constructive part of recovery.


Rebuilding Sexual Health and Personal Relationships

Cancer treatment may affect sexual desire, hormone levels, energy, physical function, body confidence, and emotional intimacy. Mastectomy scars or changes in the chest may influence how a man sees himself and how comfortable he feels with a partner.

These concerns are legitimate aspects of survivorship and should be discussed with appropriate medical, mental-health, or sexual-health professionals. Partners may also require support as they adjust to changes in roles, communication, and intimacy. Relationships can be strengthened through patience, affection, honesty, and mutual understanding.


Returning to Work and Daily Life

Returning to work can represent independence and renewed normalcy, but it may also bring physical and emotional pressure. Fatigue, pain, reduced mobility, treatment-related cognitive changes, ongoing medical appointments, or medication side effects can make an immediate return to previous responsibilities difficult.

A gradual transition may be more appropriate. Flexible hours, modified duties, scheduled rest periods, ergonomic adjustments, and temporary workplace accommodations can help survivors rebuild confidence and productivity. Occupational rehabilitation may be especially valuable when a job requires lifting, repetitive movement, travel, or sustained concentration.


Creating a Personal Definition of Recovery

Life after male breast cancer may not look exactly as it did before diagnosis. Rehabilitation is not about pretending that nothing happened. It is about helping each survivor move forward with greater strength, knowledge, and support.

Recovery includes follow-up care, appropriate surveillance, physical activity, nutritious eating, mental-health support, relationship rebuilding, and renewed personal purpose. Every man’s experience will be different, and progress should be measured according to his individual needs.

For the Male Breast Cancer Global Alliance, survivorship means more than completing treatment. It means ensuring that every man has the resources to restore his health, reconnect with loved ones, return to his community, and reclaim his quality of life.

Treatment addresses the cancer. Rehabilitation helps the whole person return to life.








Sunday, July 12, 2026

"Oh, The Changes I’ve Seen" - Op Ed by Bob Riter


I was diagnosed with breast cancer thirty years ago and I’ve attended dozens of national cancer research conferences since then. It’s a useful exercise to step back from time to time and look at the big picture. What’s changed in our understanding of cancer and cancer treatment in those three decades? (Note that this article isn’t specific to male breast cancer). Here are some of the broad themes-

Targeted Therapies: Thirty years ago, chemotherapy used a shotgun approach. Shoot and hope for the best. It wasn’t generally clear who would benefit from chemotherapy, so we gave it to most people, hoping that those who could benefit from it would benefit, and those that didn’t benefit weren’t terribly damaged by it.

Today, we’re much better able to match the drug(s) to the biology of the specific tumor. In the first national conference that I attended - the San Antonio Breast Cancer Symposium - Dr. Dennis Slamon presented the results of a trial of trastuzumab (Herceptin) which proved to be remarkably effective in the treatment of Triple Negative Breast Cancers. This was one of the first targeted cancer treatments.

Targeted treatments are wonderful because the individuals with that biological target are likely to benefit. Equally important is an understanding of who won’t benefit from that treatment.

Deescalation of Treatment: We’ve slowly evolved from thinking that the most aggressive cancer treatment is always the best cancer treatment. I’ve seen this in the surgical removal of axillary lymph nodes. Thirty years ago, it was common to have a complete axillary dissection as a routine part of any mastectomy or lumpectomy. A few years later, sentinel lymph node dissection became the standard of care and additional nodes were removed only if the sentinel nodes were positive. More recently, it’s been discovered that removing a small number of positive nodes does not provide additional benefit and a complete axillary dissection is only performed if there’s extensive axillary involvement. We increasingly realize that less treatment is often better treatment.

The Tumor Microenvironment: For most of history, our research focus has been on the biology of the cancer tumor. Over the past decade or so, we’re increasingly aware of the importance of what surrounds the tumor. (This is often referred to as the tumor microenvironment). That environment impacts the ability of the tumor to spread, and also affects the ability of drugs to reach the tumor. Immunotherapy has been one of the most important advances in cancer therapy for the past couple of decades, and it specifically activates and deactivates immune cells in that microenvironment.

Cancer as an Evolutionary Process: Finally, we’re increasingly thinking of cancer in evolutionary terms. Cancer cells constantly multiply and only the “fittest” cancer cells manage to take root in other organs. Further, while cancer treatments generally kill most cancer cells, the cancer cells that remain are - by definition - the most resistant to treatment, and those cells are the ones that continue to multiply. In the future, treatments may be designed with evolution in mind. Some cancers might be better controlled not by attempting to kill every cancer cell, but by “managing” the populations of cancer cells that are sensitive and those that are resistant to treatment.


Our knowledge of cancer continues to evolve. Had I been diagnosed today instead of in 1996, my treatment would have been quite different. I would have had a sentinel node biopsy (instead of a complete axillary dissection), and I likely would not have had chemotherapy given my tumor biology. But that’s the nature of science. We know more and treatments will continue to improve and be more personalized to each individual. I’m excited to see the changes that will take place in the next thirty years.


___________________________________________________________________________________

Advancing Research. Empowering Advocates:

Changing the Future of Male Breast Cancer.


The Male Breast Cancer Global Alliance (MBCGA) Research Committee is where science, patient advocacy, and collaboration come together to accelerate progress against male breast cancer. Committed to evidence-based decision-making, the committee serves as a trusted voice in evaluating emerging research, supporting promising scientific initiatives, and ensuring that the unique needs of men with breast cancer are represented throughout the research process.

Committee members work alongside leading investigators, pharmaceutical trial teams, clinicians, and advocacy organizations to review research proposals, contribute valuable patient perspectives, promote educational programs, and mentor the next generation of research advocates. The committee also helps ensure that MBCGA educational resources remain aligned with the latest scientific evidence while encouraging greater participation in nationally recognized advocacy training programs.

Whether you are a survivor, caregiver, healthcare professional, or advocate passionate about advancing research, the MBCGA Research Committee offers a meaningful opportunity to make a lasting impact. By connecting lived experience with scientific discovery, the committee is helping shape better treatments, stronger collaborations, and a brighter future for every man affected by breast cancer. Together, we can transform advocacy into action and research into hope.




Bob Riter

My organizational connections:

Writings:

Thursday, July 9, 2026

Spotlight: Dr. Neil M. Iyengar, MD

The Emerging Role of Metabolic Health in Male Breast Cancer Research

Reflections Following a Strategic Meeting Between the Male Breast Cancer Global Alliance and Emory University

By Lennard M. Goetze, Ed.D. / Dr. Robert Bard
Executive Director, AngioInstitute

On June 10, 2026, representatives of the Male Breast Cancer Global Alliance (MBCGA) met with Dr. Neil M. Iyengar, MD, breast medical oncologist, physician-scientist, and Director of Survivorship Services at Emory University's Winship Cancer Institute. The meeting was organized by Cheri Ambrose, CEO of the Male Breast Cancer Global Alliance, as part of the organization's continuing effort to engage leading investigators whose work has the potential to influence the future direction of breast cancer research, survivorship, and patient-centered care.

Participants included Dr. Robert L. Bard, Chief Clinical Advisor to MBCGA; Daniel Root, Associate Director of Communications; and Lennard M. Goetze, Ed.D., representing the AngioInstitute and its affiliated research and publishing initiatives. The primary purpose of the meeting was to discuss emerging research priorities in breast oncology, explore opportunities for collaborative investigation, and formally invite Dr. Iyengar to join the Medical Advisory Board of the Male Breast Cancer Global Alliance.

The invitation was motivated not only by Dr. Iyengar's clinical expertise, but also by his increasingly influential body of work examining the relationship between metabolic health, lifestyle factors, and cancer outcomes.

Expanding the Framework of Breast Cancer Research

Traditional oncology has historically focused on the biological characteristics of tumors themselves. Increasingly, however, researchers are recognizing that tumor behavior cannot be fully understood without examining the physiologic environment in which malignancies develop and progress.

Dr. Iyengar's research program reflects this broader perspective. During the discussion, he described his work as focusing on "the intersections of metabolic health and lifestyle with both cancer risk and cancer outcomes."

His investigations examine the role of obesity, insulin signaling, inflammation, adipose tissue biology, and body composition in cancer development and survivorship. These factors collectively influence what researchers increasingly describe as the tumor microenvironment—a dynamic ecosystem that may either promote or suppress malignant progression.

As Dr. Iyengar explained, most breast cancers arise within tissue environments dominated by adipose tissue. Consequently, the metabolic state of the individual becomes clinically relevant. "Most breast tumors arise within a microenvironment that's predominantly comprised of fat cells," he noted. "Poor metabolic health and states of energy imbalance can change the tumor microenvironment in a way that supports tumor growth."

This line of investigation has significant implications for both prevention and survivorship. It suggests that interventions directed toward metabolic optimization may ultimately complement conventional treatment strategies by modifying biological conditions associated with disease progression.

From Survivorship to Prevention

Among Dr. Iyengar's most significant contributions has been his leadership in survivorship medicine. As Director of Survivorship Services at Winship Cancer Institute, he oversees the development and integration of evidence-based programs designed to address the long-term needs of cancer survivors. These initiatives extend beyond traditional follow-up care and incorporate nutrition, exercise, supportive care, behavioral interventions, and lifestyle modification.

His previous work at Memorial Sloan Kettering Cancer Center resulted in the development of the Healthy Living Program, an innovative survivorship model designed to create individualized wellness strategies for patients during and after cancer treatment.

Such efforts reflect a growing recognition that survivorship should not be viewed merely as the period following treatment. Rather, survivorship represents a continuum of care that begins at diagnosis and extends throughout the patient's lifespan.

This philosophy aligns with an expanding body of literature demonstrating that exercise, nutrition, body composition, and metabolic regulation may influence recurrence risk, treatment tolerance, quality of life, and overall survival.

Relevance to Male Breast Cancer

Although the majority of breast cancer research understandably focuses on women, male breast cancer remains an area of considerable unmet need. The rarity of the disease presents challenges for investigators seeking to conduct adequately powered studies. Consequently, many clinical recommendations for men are extrapolated from data generated in female populations.

Dr. Iyengar emphasized that such extrapolations may overlook important biological differences. "I have treated and still treat a lot of men with breast cancer," he stated. "The metabolic status of a male versus a post-menopausal female, for example, is very, very different."

This observation has substantial implications for future research. Differences in hormonal physiology, body composition, adipose tissue distribution, and metabolic regulation may influence both disease development and treatment response.

Accordingly, Dr. Iyengar noted that there is a need to examine these questions directly within male populations. "I really think that there's a need to study metabolic health specifically in men." His comments highlight a growing opportunity within male breast cancer research: the development of biologically informed investigations that move beyond simple adaptation of female-centered models.

Challenges in Rare Disease Research

The conversation also addressed one of the most persistent barriers facing male breast cancer investigators: patient recruitment. Dr. Iyengar described a prior research concept involving male breast cancer patients that encountered practical limitations because of anticipated accrual challenges.

"We thought the grant would be criticized for the ability to accrue 40 male breast cancer patients within two years at a single center." This challenge is not unique to male breast cancer. Rare diseases frequently require multi-institutional collaboration to achieve meaningful sample sizes.

The discussion therefore shifted toward opportunities for national recruitment networks, collaborative publishing initiatives, and multi-center research models capable of supporting future investigations. In this regard, the Male Breast Cancer Global Alliance serves an important function by connecting researchers, advocacy organizations, clinicians, survivors, and healthcare systems that may otherwise operate independently.

Survivorship Resources for Men

A particularly important observation emerged regarding survivorship programming. Dr. Iyengar noted that many existing exercise and wellness initiatives remain primarily designed around female breast cancer populations.

"A lot of the lifestyle programs for breast cancer—the diet and exercise programs—are really geared towards women," he explained. While these programs provide substantial value, their design may unintentionally limit engagement among male survivors. This observation reinforces the need for educational resources, rehabilitation programs, exercise interventions, and survivorship models specifically developed for men diagnosed with breast cancer.

As survivorship continues to evolve as a discipline, such considerations may become increasingly important components of comprehensive care.

Appointment to the Medical Advisory Board

Following discussion of these topics, Cheri Ambrose formally invited Dr. Iyengar to join the Medical Advisory Board of the Male Breast Cancer Global Alliance. The invitation reflects recognition of his scholarly contributions to breast oncology, his leadership in survivorship medicine, and his commitment to advancing understanding of the relationship between metabolic health and cancer outcomes.

Dr. Iyengar accepted the invitation, expressing interest in participating in future educational and research initiatives. His appointment adds an important perspective to the advisory board, particularly in areas involving lifestyle medicine, survivorship science, metabolic health, and translational oncology.

Conclusion

The June 10 meeting highlighted several themes that are likely to influence the next generation of breast cancer research: precision lifestyle interventions, survivorship science, metabolic health, collaborative investigation, and the unique needs of men diagnosed with breast cancer.

Dr. Neil M. Iyengar's work occupies a strategic position at the intersection of these emerging disciplines. His research challenges investigators to look beyond the tumor itself and consider the broader biological, behavioral, and metabolic factors that shape cancer outcomes.

For the Male Breast Cancer Global Alliance, the addition of Dr. Iyengar to its Medical Advisory Board represents an opportunity to strengthen scientific dialogue surrounding an often-overlooked patient population. More importantly, it reflects a shared commitment to advancing evidence-based approaches that improve prevention, treatment, survivorship, and quality of life for individuals affected by breast cancer.

As male breast cancer research continues to mature, collaborative relationships between clinicians, scientists, advocacy organizations, and survivors will become increasingly essential. The June 10 discussion represents one step in that process and underscores the value of bringing together diverse expertise in pursuit of common goals.


-----------------------------------------------------------------------------------------------------------------------------




Three Decades of Progress: How Cancer Care Has Been Transformed

By: Bob Ritter

Bob Riter brings the rare perspective of someone who has lived through—and helped shape—three decades of cancer advocacy. In this compelling reflection, he explores the extraordinary evolution of cancer care, from the era of one-size-fits-all chemotherapy to today's precision medicine, targeted therapies, immunotherapy, and personalized treatment strategies. With insight drawn from years of attending leading research conferences, Riter explains how science continues to redefine what is possible while improving both outcomes and quality of life. His inspiring look back reminds us that every breakthrough builds hope for the next generation of patients and survivors. 

SEE COMPLETE FEATURE


Advancing Research. Empowering Advocates. Changing the Future of Male Breast Cancer.

The Male Breast Cancer Global Alliance (MBCGA) Research Committee is where science, patient advocacy, and collaboration come together to accelerate progress against male breast cancer. Committed to evidence-based decision-making, the committee serves as a trusted voice in evaluating emerging research, supporting promising scientific initiatives, and ensuring that the unique needs of men with breast cancer are represented throughout the research process.

Committee members work alongside leading investigators, pharmaceutical trial teams, clinicians, and advocacy organizations to review research proposals, contribute valuable patient perspectives, promote educational programs, and mentor the next generation of research advocates. The committee also helps ensure that MBCGA educational resources remain aligned with the latest scientific evidence while encouraging greater participation in nationally recognized advocacy training programs.

Whether you are a survivor, caregiver, healthcare professional, or advocate passionate about advancing research, the MBCGA Research Committee offers a meaningful opportunity to make a lasting impact. By connecting lived experience with scientific discovery, the committee is helping shape better treatments, stronger collaborations, and a brighter future for every man affected by breast cancer. Together, we can transform advocacy into action and research into hope.


Thursday, July 2, 2026

Innovative Virtual Photography (IVP)

A New Era of Authentic Survivor Advocacy Through Artificial Intelligence

Public health communication has always relied on compelling imagery to educate, inspire, and motivate communities. Whether promoting early detection, survivorship, rehabilitation, or advocacy, the visual message often speaks louder than words. For organizations serving patients and survivors, authenticity is essential. Real stories deserve real faces.

The Male Breast Cancer Global Alliance (MBCGA) has embraced this philosophy by introducing an innovative communications platform known as Innovative Virtual Photography (IVP)—a proprietary imaging methodology that enables the creation of personalized, high-quality visual assets using artificial intelligence while preserving the identity and spirit of each participant.

IVP represents a new direction in nonprofit communications. Rather than relying on generic stock photography that may fail to accurately represent the communities being served, this technology allows MBCGA to feature actual male breast cancer survivors in campaigns throughout the year. The result is a library of authentic visual content that can be adapted for awareness campaigns, educational materials, fundraising initiatives, newsletters, social media, conference presentations, and public service announcements.

Every survivor has a story worth telling. IVP provides an innovative way to tell that story visually.  For advocacy organizations, visual consistency has traditionally been one of the greatest challenges. Organizing multiple professional photo shoots requires scheduling, travel, photographers, studio space, lighting, wardrobe coordination, and significant financial resources. These logistical obstacles often limit the diversity and quantity of available imagery.

Innovative Virtual Photography removes many of these barriers by combining remote participation with advanced artificial intelligence. Through a guided online session, survivors can contribute to a growing portfolio of personalized visual assets from virtually anywhere. Once established, this digital catalog can support future campaigns without requiring repeated photography sessions.

For the Male Breast Cancer Global Alliance, this means greater efficiency while maintaining the human connection that defines effective advocacy.

Unlike anonymous stock photographs, IVP celebrates the genuine faces of survivorship. Members of the public are more likely to connect with authentic individuals who have experienced diagnosis, treatment, recovery, and rehabilitation firsthand. These images communicate hope, resilience, and credibility because they represent the real people behind the mission.

This approach also strengthens community identity. Survivors become ambassadors for awareness, encouraging other men to seek education, screening, and support. Every campaign reinforces the message that male breast cancer is real, survivorship is possible, and no individual faces the journey alone.


How Does IVP Work?

The IVP process begins with a scheduled online video session, typically conducted through a secure Zoom meeting. During each session, Communications Director Lennard Goetze guides participants through a carefully designed sequence of facial expressions and viewing angles.

The process is intentionally simple and comfortable. Participants are asked to face the camera while performing a variety of natural expressions, including relaxed, smiling, laughing, thoughtful, serious, hopeful, and determined looks. Additional head positions include looking left, right, upward, downward, and at intermediate angles. These guided movements create a comprehensive visual reference of each participant's facial structure and expressions.

Throughout the session, high-resolution screen captures are obtained under consistent viewing conditions. These reference images provide the foundation for the participant's personalized digital profile.

Additional observations of upper-body proportions help establish approximate body dimensions, posture, and overall physique. Rather than requiring a complete professional photo session, these reference materials provide sufficient information for the next stage of production.

Using proprietary artificial intelligence technology, the software analyzes these visual references and generates an extensive range of image possibilities while preserving the recognizable identity of the individual survivor. Digital artists then refine the output by combining the participant's facial characteristics with an extensive catalog of anatomically appropriate body references, poses, gestures, wardrobe selections, environments, and lighting conditions. This hybrid workflow combines human artistic direction with advanced AI-assisted rendering.

The final images may portray survivors exercising during rehabilitation, speaking at conferences, participating in awareness walks, celebrating milestones, embracing family members, engaging in community outreach, or standing as symbols of hope during national awareness campaigns. Each illustration remains faithful to the participant's appearance while allowing virtually unlimited creative flexibility for educational storytelling.

The result is an expanding visual library capable of supporting communications throughout the year without repeated studio photography.

The advantages extend beyond efficiency. IVP dramatically reduces production costs while increasing creative possibilities. Campaigns can be developed more rapidly, adapted for seasonal awareness initiatives, or customized for specific educational topics. New posters, brochures, newsletters, websites, fundraising appeals, and social media graphics can be created using familiar survivor ambassadors who already represent the organization.

For the Male Breast Cancer Global Alliance, this technology supports an important philosophical goal: placing survivors—not anonymous models—at the center of every message.

Innovation in healthcare extends beyond diagnostics, treatment, and rehabilitation. It also includes how organizations communicate with the public. By embracing emerging technologies responsibly, advocacy organizations can strengthen education while preserving the human stories that inspire action.

Innovative Virtual Photography demonstrates how artificial intelligence can enhance—not replace—the human experience. Technology serves as a creative tool that amplifies authentic voices, allowing real survivors to continue educating the public long after a single photo session has ended.

As awareness campaigns become increasingly digital, organizations require flexible, scalable, and believable visual resources. IVP offers a practical solution that combines authenticity, efficiency, artistic creativity, and technological innovation into a single communications platform.

For the Male Breast Cancer Global Alliance, every image tells more than a story—it represents courage, resilience, hope, and the shared commitment to ensuring that no man faces breast cancer alone. Through Innovative Virtual Photography, survivors continue to educate, inspire, and advocate, one powerful image at a time.

Sunday, June 28, 2026

Psychological Survivorship After Cancer Therapy

Understanding Mental Health Recovery Following Heavy Treatments

Jessica Connell, LCSW & Barbara Bartlik, MD

The completion of chemotherapy or radiation therapy has traditionally been regarded as the conclusion of active cancer treatment. From a clinical perspective, however, the termination of oncologic intervention frequently represents the beginning of a second phase of care known as survivorship. While contemporary oncology has made remarkable advances in improving disease-free survival and overall longevity, increasing attention has been directed toward the long-term psychological and neurocognitive consequences experienced by survivors. Mental health recovery has emerged as a critical component of comprehensive survivorship, requiring structured evaluation and interdisciplinary support comparable to physical rehabilitation.

Cancer is not solely a biological disease. It constitutes a prolonged psychological stressor that challenges nearly every dimension of an individual's functioning, including cognition, emotional regulation, interpersonal relationships, occupational performance, self-image, and existential perspective. Throughout treatment, patients frequently develop adaptive coping mechanisms focused upon immediate survival. Once treatment concludes, however, these protective mechanisms often give way to unresolved psychological distress that becomes increasingly apparent as individuals attempt to resume pre-diagnosis roles and responsibilities.

The prevalence of mental health concerns among cancer survivors is substantial. Anxiety disorders remain among the most commonly reported complications, often characterized by persistent fear of recurrence, heightened vigilance toward normal bodily sensations, anticipatory distress surrounding surveillance imaging, and uncertainty regarding future health. Depressive symptoms may emerge concurrently, presenting as diminished motivation, impaired concentration, emotional withdrawal, loss of pleasure, fatigue disproportionate to physical recovery, and alterations in sleep architecture. While these symptoms vary considerably among individuals, they collectively illustrate that survivorship extends beyond remission to encompass long-term psychological adaptation.

An additional dimension of post-treatment recovery involves neurocognitive dysfunction commonly referred to as cancer-related cognitive impairment or "chemotherapy-associated cognitive dysfunction." Although colloquially described as "chemo brain," the phenomenon encompasses a broader constellation of impairments involving attention, executive functioning, processing speed, working memory, verbal recall, and multitasking ability. These changes may persist for months or, in some individuals, several years following treatment. Importantly, such cognitive disturbances are not solely attributable to chemotherapy itself but may also reflect cumulative effects of systemic inflammation, endocrine disruption, fatigue, emotional distress, sleep disturbances, concurrent medications, and the neurobiological consequences of chronic psychological stress.

These cognitive changes frequently produce secondary emotional consequences. Individuals who previously functioned at high professional or academic levels may experience frustration, embarrassment, diminished confidence, and concern regarding their ability to return to previous occupational responsibilities. Consequently, cognitive impairment often contributes indirectly to social isolation, vocational uncertainty, and reduced self-efficacy.

Cancer survivorship also requires substantial identity reconstruction. During treatment, patients commonly adopt the role of "cancer patient," with daily life organized around medical appointments, treatment schedules, diagnostic testing, and symptom management. Following completion of therapy, the abrupt withdrawal of this structured environment frequently creates psychological disequilibrium. Survivors often describe uncertainty regarding how to define themselves beyond illness, particularly when family members and colleagues assume that recovery is complete despite persistent emotional or cognitive difficulties. This discrepancy between external expectations and internal experience may further complicate psychological adjustment.

The restoration of mental health therefore requires deliberate intervention rather than passive observation. Contemporary survivorship models increasingly recognize psychological rehabilitation as an integral component of comprehensive cancer care. Early identification of anxiety, depression, adjustment disorders, trauma-related symptoms, sleep disorders, and cognitive dysfunction permits timely intervention before secondary complications develop.

Psychotherapeutic intervention represents one of the most effective strategies for facilitating psychological recovery. Individual psychotherapy provides survivors with a structured environment in which to process fear, grief, altered self-perception, and uncertainty regarding the future. Evidence-based approaches including Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), mindfulness-based cognitive therapy, supportive psychotherapy, and trauma-informed interventions have demonstrated measurable benefit in reducing emotional distress while improving adaptive coping mechanisms and quality of life. Equally important is psychoeducation, enabling survivors and their families to recognize that emotional and cognitive symptoms represent expected components of survivorship rather than indicators of personal weakness or treatment failure.

The process of cognitive rehabilitation similarly benefits from structured intervention. Neuroplasticity permits meaningful functional recovery through repeated cognitive engagement. Activities involving reading, memory exercises, strategic problem solving, language acquisition, executive functioning tasks, and computerized cognitive training may enhance neural efficiency while restoring confidence in cognitive performance. Occupational therapy and neuropsychological consultation may further assist survivors experiencing persistent deficits that interfere with vocational or daily functioning.

Lifestyle modification constitutes another essential component of psychological recovery. Physical activity has consistently demonstrated positive effects upon mood regulation, cognitive performance, sleep quality, inflammatory modulation, and overall neurological health. Nutritional optimization, restoration of circadian rhythm, adequate hydration, and management of chronic fatigue collectively contribute to improved psychological resilience. Equally important is the gradual re-establishment of meaningful social interaction, vocational engagement, recreational activities, and community participation, each of which reinforces a renewed sense of purpose and personal identity.

Confidence frequently represents the final domain to recover. Following months of medical intervention, many survivors develop understandable apprehension regarding physical symptoms, future health, or their capacity to resume previous responsibilities. Confidence cannot simply be restored through reassurance alone; rather, it develops progressively through repeated experiences of successful adaptation. Incremental achievement, realistic goal-setting, supportive therapeutic relationships, and ongoing clinical follow-up collectively strengthen an individual's belief in his or her capacity to function beyond the cancer experience.

Modern survivorship therefore requires a paradigm that extends beyond disease surveillance alone. Long-term outcome measures should encompass psychological well-being, cognitive functioning, vocational reintegration, interpersonal relationships, and overall quality of life in addition to traditional oncologic endpoints. As survival rates continue to improve across numerous malignancies, healthcare systems bear increasing responsibility for addressing the enduring emotional and neurocognitive consequences of treatment.

Survivorship should not be conceptualized as the absence of disease, but rather as the restoration of adaptive functioning across physical, psychological, cognitive, and social domains. Comprehensive recovery is achieved not only through successful eradication of cancer but through the preservation and rehabilitation of the individual's capacity to engage meaningfully with work, family, community, and personal purpose. Mental health is therefore not ancillary to survivorship care; it is one of its defining clinical outcomes.






PART 2

HOPE THROUGH REHABILITATION:

Rebuilding Quality of Life After Cancer Through Movement, Nutrition, and Preventive Imaging

By Robert L. Bard, MD

Cancer survivorship extends well beyond the successful completion of surgery, chemotherapy, or radiation therapy. While eliminating disease remains the primary objective of oncology, the restoration of physical function, emotional well-being, and long-term health has become an equally important component of comprehensive cancer care. Rehabilitation should therefore be regarded not as an optional service, but as a structured medical strategy designed to restore quality of life while reducing the risk of future health complications.

Cancer treatment frequently produces long-lasting physiological changes that include muscle deconditioning, chronic fatigue, neuropathy, reduced cardiovascular endurance, weight fluctuations, joint stiffness, and metabolic alterations. Left unaddressed, these consequences may significantly impair functional independence and diminish overall health despite successful cancer treatment. Rehabilitation provides survivors with an opportunity to reverse many of these effects through individualized interventions that promote recovery rather than simple maintenance.

Exercise represents one of the most extensively studied components of cancer rehabilitation. Carefully prescribed aerobic activity, resistance training, flexibility exercises, and balance conditioning have demonstrated benefits in improving muscular strength, cardiovascular fitness, mobility, fatigue, and overall physical performance. Equally important, regular physical activity contributes to improved immune function, healthier body composition, enhanced metabolic regulation, and better psychological resilience. Rehabilitation should therefore encourage consistent movement that is individualized according to each survivor's medical history, treatment-related limitations, and functional goals.

Nutrition constitutes another essential pillar of survivorship. Recovery requires adequate protein for tissue repair, anti-inflammatory dietary patterns, optimal hydration, and nutritional strategies that support immune function while reducing cardiovascular and metabolic risk factors. Rather than focusing solely upon weight management, nutritional rehabilitation should emphasize restoring physiological resilience and promoting long-term health across multiple organ systems.

An equally important component of survivorship is active surveillance. Rehabilitation is most effective when accompanied by objective monitoring of the body's ongoing recovery. Modern diagnostic imaging allows clinicians to evaluate musculoskeletal healing, vascular integrity, lymphatic function, soft tissue abnormalities, and other treatment-related changes before symptoms become clinically significant. Ultrasound, in particular, offers a safe, non-invasive, and repeatable method for assessing many superficial tissues without ionizing radiation, allowing clinicians to document recovery while identifying conditions that may benefit from early intervention.

Preventive imaging should not be viewed solely as a means of detecting recurrent malignancy. It also serves as an important instrument for evaluating the broader health of the cancer survivor. Identifying inflammation, fibrosis, musculoskeletal injury, vascular compromise, or treatment-related tissue changes at an early stage allows rehabilitation programs to be modified proactively rather than reactively.

The future of survivorship care lies in the integration of rehabilitation, preventive medicine, nutritional science, physical conditioning, and advanced diagnostic imaging. By combining these disciplines within a coordinated care model, clinicians can help survivors restore functional independence, improve long-term health outcomes, and regain confidence in their physical abilities.

Surviving cancer represents a significant medical achievement. Helping individuals reclaim an active, productive, and fulfilling life thereafter represents the next evolution of comprehensive cancer care.


About the Author

Robert L. Bard, MD, is an internationally recognized diagnostic imaging specialist and pioneer in advanced non-invasive cancer imaging. For more than five decades, he has dedicated his career to improving the early detection, characterization, and surveillance of cancer through innovative applications of 3D Doppler ultrasound, MRI, and image-guided technologies. Dr. Bard has authored numerous scientific publications, lectures internationally, and collaborates with multidisciplinary teams advancing precision diagnostics, survivorship, and preventive medicine. His clinical philosophy emphasizes early detection, active surveillance, and personalized imaging strategies that empower patients throughout every stage of cancer care and long-term recovery. Learn more at www.thecancerdetective.org.



PART 3

COMING HOME TO YOURSELF: The Journey Beyond Cancer Survival

By Anette DeMattio, MA

 

In the first two articles of this series, Jessica Connell and Dr. Barbara Bartlik explored what happens to the mind after cancer, while Dr. Robert Bard explored what happens to the body.

Reading them, I exhaled.

For the first time in more than thirty years, I understood what had happened to me. Not just to my body but to the way I think, the way I remember, the way I move through the world.  In six cancer diagnoses across a lifetime, no one had ever told me that what I was experiencing after treatment had a name. That I wasn’t imagining it. That I wasn’t failing at recovery. Recovery wasn’t simply about healing my brain. It was about rebuilding my relationship with it. Treatment ends. Recovery doesn’t.

I’d like to offer the view from inside, and to ask you to walk this part of the journey with me, because I don’t believe any of us were meant to walk it alone.

I still search for words. Every day.

There was a time when I could facilitate a room full of executives, coach leaders through life-changing decisions, and juggle six projects without thinking twice. Today, I keep twenty-five tabs open on my screen because I’m afraid that if I close one, I’ll forget where I was.

Reading their description of the lasting cognitive effects of cancer,  shaped not only by chemotherapy but by chronic stress and the burden of surviving, gave me something I wish every survivor received far earlier.

Self-compassion. I wasn’t weak. My brain and nervous system had been surviving for years. Recovery wasn’t simply about healing. It was about rebuilding trust. If I had known this thirty years ago, I would have been gentler with myself. I wasn’t only grieving what my brain could no longer do. I was grieving the woman I thought I’d lost.

And that kind of loss? When you lose confidence in your own mind, you slowly begin losing confidence in yourself. Yet for many survivors, it becomes one of the deepest wounds cancer leaves behind. Because cancer isn't only a diagnosis. It's a trauma the body remembers long after treatment ends.

I realized that on an ordinary afternoon. An executive sat across from me, complaining that money was tight and he wouldn’t be able to use his boat that summer. I remember listening. I remember another conversation happening entirely inside my own head. You want to know suffering? Try being a single mother of two young daughters, facing cancer for the fifth time while worrying about their health too.

The thought startled me. For my whole career, my gift had always been helping people carry their hardest moments. That day, I couldn’t carry another. I thought I’d lost my compassion. I hadn’t. I was exhausted. The woman who had spent decades carrying everyone else had finally reached the point where she could no longer carry herself. That afternoon became my last day in corporate work.

For me, it was work. Later, it was a relationship I finally let go of. For someone else, it may be something entirely different. But there is often a moment when the life we’ve been holding together can no longer hold us. And what changes isn’t our circumstances. It’s our identity.

What no one tells you is how lonely survivorship can become. I spent a small fortune trying to piece myself back together. Some of it helped. None of it gave me what these articles finally did. Language. Because once we can name an experience, we stop believing we’re the only one living it. Shame begins to loosen. Slowly, we begin trusting ourselves again.

We often talk about surviving. Then thriving. Both matter. But I have come to believe there is one more step. Evolving. Cancer didn’t teach me who I was. It slowly stripped away who I wasn’t. Long before anyone found a tumor, I’d already become an expert at surviving. Pushing through. Performing strength. Believing my worth lived in how much I could carry. Cancer didn’t create those patterns. It revealed them. The problem was never that I became strong. The problem was that I forgot strength was an adaptation — not my identity.

The first two articles remind us that survivorship is about more than the absence of disease. I’d simply add one more dimension. The rehabilitation of the self. Because after treatment ends, it isn’t only our bodies and minds that need rebuilding. It’s the relationship we’ve lost with ourselves. Trust in our minds. Trust in our bodies. Trust in ourselves. Because trust isn’t the destination. It’s the bridge back to the self beneath survival.

Looking back, I don’t think what nearly broke me was cancer. It was believing I had to become the woman I had been before it. She no longer existed. And maybe she was never meant to. Maybe the deepest work of survivorship isn’t returning to who we were before cancer. It’s allowing everything survival built around us to fall away, until all that’s left is the truest version of ourselves. The one that was there underneath it all — long before the diagnosis, long before survival became our identity. Waiting patiently for us to come home.


ABOUT THE AUTHOR:

Anette DeMattio is a six-time cancer survivor, author, speaker, and transformational coach whose work explores the profound emotional journey beyond survival. Drawing from decades of leadership coaching and her own lived experience with cancer and chronic pain, she developed The Too Strong Method™, helping individuals recognize the hidden cost of always being "the strong one." Her writing challenges traditional notions of recovery by emphasizing the restoration of identity, self-trust, and authentic living. Through compassionate insight and personal wisdom, Anette inspires survivors, caregivers, healthcare professionals, and leaders to move beyond resilience and rediscover the truest version of themselves.


 

The MBCGA Reclaiming Life Program

SURVIVORSHIP: A STRATEGY FOR RECLAIMING LIFE Developed from interviews with male breast cancer survivors A diagnosis of male breast cancer c...